CellCentric raises $26 million to take first-in- class p300/CBP inhibitor into the clinic.

[paulofaus]

Hey Guys, I came across this whilst doing some research yesterday. Looks promising, especially for our castration resistant brothers from the UK. cellcentric.com/press-relea... .